Respiratory disease companies develop therapies, diagnostics and research technologies for conditions affecting the lungs and airways. Their work supports earlier detection, improved disease monitoring and the development of treatments for acute, chronic and inherited pulmonary disorders.
This category includes companies working on:
Browse 65 UK respiratory disease companies below.
Global influenza vaccine leader with major UK manufacturing in Liverpool
CSL Seqirus is one of the world's largest influenza vaccine companies, operating the only injectable influenza vaccine manufacturing facility in the UK at Speke, Liverpool. The…
Inhaled interferon beta therapy for severe viral lung infections
Synairgen is a clinical-stage biopharmaceutical company developing an inhaled formulation of interferon beta as a broad-spectrum antiviral therapy for severe respiratory viral…
Decentralised clinical trial site bringing research to participants
The Virtual Clinical Trial Centre is a clinical research organisation operating a network of flexible, patient-centric trial sites across the UK and Spain. Its decentralised model…
Finnish pharma company marketing and developing medicines
Orion Pharma (UK) Limited is the UK subsidiary of Orion Corporation, a Finnish pharmaceutical company. The UK entity manages commercial operations for Orion's prescription…
Nitric oxide therapeutics developer for infectious and respiratory disease
30 Technology is a clinical-stage biopharmaceutical company developing nitric oxide-generating therapies for the treatment of antimicrobial-resistant infections and chronic…